Novella Clinical Partners with Academia on CV Clinical Trials Services
Novella Clinical and the Cardiovascular Research Foundation announced a preferred provider collaboration.
Novella Clinical, a Quintiles company, and the Cardiovascular Research Foundation announced a preferred provider collaboration that will offer a set of clinical trial services to developers of cardiovascular drugs and devices. Novella, is a full-service clinical research organization with specialization in cardiovascular medical device research, and the Cardiovascular Research Foundation Clinical Trials Center, the academic research organization of the Foundation, with its extensive group of cardiovascular physicians and core labs, will work together to provide sponsors comprehensive clinical research services-from preclinical to post-market studies.
Read the full release here.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
